HYPOGLYCEMIC DRUGS AND THE DEXTRAN 'ANAPHYLACTOID' INFLAMMATION
- 1 August 1960
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Biochemistry and Physiology
- Vol. 38 (8) , 823-827
- https://doi.org/10.1139/o60-101
Abstract
Tolbutamide (Orinase) (260 mg/kg s.c), a hypoglycemic drug of the sulphonylurea class, sensitizes the normal rat (135–185 g) towards the 'anaphylactoid' inflammation induced by the administration of dextran (1 ml 6% w/v solution in saline s.c. per rat). However, the drug does not sensitize the alloxan diabetic rat towards this inflammation, nor does it alleviate the classical signs of alloxan diabetes. It is suggested that the sensitization of normal rats towards dextran by tolbutamide is mediated through insulin.Keywords
This publication has 7 references indexed in Scilit:
- Glucose and the dextran ‘anaphylactoid’ inflammationAmerican Journal of Physiology-Legacy Content, 1960
- Inhibition of anaphylactoid edema in the rat by 2-deoxyglucoseAmerican Journal of Physiology-Legacy Content, 1959
- Alloxan diabetes and dextran "anaphylactoid" inflammationAmerican Journal of Physiology-Legacy Content, 1959
- Glucagon, insulin and ‘anaphylactoid’ inflammationThe Journal of Physiology, 1959
- Inhibition of Histamine Release in Experimental DiabetesAmerican Journal of Physiology-Legacy Content, 1957
- THE EFFECT OF pH ON THE DIABETOGENIC ACTION OF ALLOXANJournal of Endocrinology, 1954
- Influence of inoculation site upon the course of the “anaphylactoid reaction” to dextranJournal of Allergy, 1954